Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Vecchiarelli, S. [1 ]
D'Incecco, A. [2 ]
Minuti, G. [1 ]
Gallo, M. [3 ]
De Luca, A. [3 ]
Landi, L. [1 ]
Bennati, C. [1 ]
Spreafico, M. [4 ]
D'Arcangelo, M. [1 ]
Attilia, L. [1 ]
Mazza, V. [1 ]
Normanno, N. [3 ]
Cappuzzo, F. [1 ]
机构：
[1] Ausl Romagna, Oncohematol Dept, Ravenna, Italy
[2] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy
[3] Fdn Giovanni Pascale, Ircc, Inst Nazl Tumori, Cell Biol & Biotherapy Unit, Naples, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori Irst, Unit Biostat & Clin Trials, Ravenna, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Immunotherapy; PD-L1; Non-Small Cell Lung Cancer (NSCLC);
D O I：
10.1016/j.jtho.2017.09.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB071
引用
收藏
页码：S2389 / S2389
页数：1
相关论文
共 50 条
  • [41] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [43] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [44] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Non-small cell lung cancers (NSCLC) and programmed death ligand 1 (PD-L1) testing: multicentric analysis of clinical, pathological and molecular features
    Elshiekh, M.
    Mani, A.
    Kitson, R.
    Josephides, E.
    Clifford, A.
    Desai, S.
    Gupta, N.
    Bowen, F.
    Berry, M.
    Bloch, S.
    Ross, C.
    Counihan, I.
    Anderson, J. R.
    Nandi, J.
    Roddie, M.
    Copley, S.
    Hatcher, O.
    Denton, A.
    Power, D.
    Lewanski, C.
    Newsom-Davis, T.
    Viola, P.
    LUNG CANCER, 2018, 115 : S52 - S53
  • [46] Inter-Observer Variability in Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Scoring in Non-Small Cell Lung Cancer (NSCLC) Cytologic Specimens
    Sinclair, William
    Kobalka, Peter
    Ren, Rongqin
    Beshai, Boulos
    Limbach, Abberly Lott
    Wei, Lai
    Li, Zaibo
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 424 - 425
  • [47] Inter-Observer Variability in Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Scoring in Non-Small Cell Lung Cancer (NSCLC) Cytologic Specimens
    Sinclair, William
    Kobalka, Peter
    Ren, Rongqin
    Beshai, Boulos
    Limbach, Abberly Lott
    Wei, Lai
    Li, Zaibo
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 424 - 425
  • [48] Integrating programmed cell death ligand 1 (PD-L1) and neutrophil to lymphocyte ratio (NLR) as predictive panel of response to nivolumab in non-small cell lung cancer NSCLC)
    Bennati, C.
    Mazza, V.
    D'Arcangelo, M.
    Minuti, G.
    Vecchiarelli, S.
    Attilia, L.
    Gili, A.
    Montanari, M.
    Landi, L.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Neutrophil-to-lymphocyte ratio (NLR) trends and treatment response to programmed death/ligand 1 (PD-1/PD-L1) inhibitors in non-small cell lung cancer (NSCLC)
    Yang, H.
    Jayaprakash, K. Thippu
    Aslam, S.
    Jeffs, Y.
    Jessop, S.
    Mckay, N.
    Cawood, H.
    Bulusu, V. R.
    LUNG CANCER, 2019, 127 : S41 - S42
  • [50] Inter-observer variability in programmed death-ligand 1 (PD-L1) immunohistochemistry scoring in non small cell lung cancer (NSCLC)
    Thai, A.
    Rivalland, G.
    Asadi, K.
    Murone, C.
    John, T.
    Mitchell, P.
    ANNALS OF ONCOLOGY, 2016, 27
12345